QR kód

Taiwan Clinical Practice Guidelines for Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by muscle weakness and fatigue due to autoantibodies impairing neuromuscular transmission. With a global prevalence of 40–180 per million, Taiwan has seen a rise in MG cases from 4476 in 2013 to 5752 in 2019, with generaliz...

Celý popis

Uloženo v:
Hlavní autoři: Hsu-Ling Yeh, Che-Cheng Chang, An-Bang Liu, Meng-Han Tsai, Long-Sun Ro, Yi-Chen Chang, Tung-Yu Tiong, Jen-Jen Su, Yi-Chung Lee, Yu-Ning Huang, Shu-Lang Liao, Thy-Sheng Lin, Yi-Chu Liao, Chen-Chih Chung, Kuo-Hsuan Chang, Shu-Ping Chao, Yuan-Ting Sun, Yuh-Cherng Guo, Chin-Chang Huang, Wei-Ting Chiu, Chiung-Mei Chen, Ming-Hsing Chang, Chi-Chao Chao, Cheng-Che Chou, I-Jun Chou, Yung-Ting Kuo, Anne Chang, Chen-Shu Chang, Mei-Yun Cheng, Kuan-Yu Lin, Kon-Ping Lin, Wei-Hung Chen, Jung-Lung Hsu, Chih-Chao Yang, Nai-Wen Tsai, Jiann-Horng Yeh, Hou-Chang Chiu
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Medknow Publications 2026-04-01
Edice:Acta Neurologica Taiwanica
Témata:
autoimmune disorder
consensus guidelines
myasthenia gravis
neuromuscular junction
taiwan
On-line přístup:https://journals.lww.com/10.4103/ant.ANT-D-25-00063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky